Intermittent androgen suppression for locally advanced and metastatic prostate cancer: Preliminary report of a prospective multicenter study
- 1 August 2004
- Vol. 64 (2) , 341-345
- https://doi.org/10.1016/j.urology.2004.03.032
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 13 references indexed in Scilit:
- Intermittent androgen suppression in prostate cancer: the Canadian experienceUrology, 2002
- Bone Loss following Hypogonadism in Men with Prostate Cancer Treated with GnRH AnalogsJournal of Clinical Endocrinology & Metabolism, 2002
- Intermittent androgen deprivation: update of cycling characteristics in patients without clinically apparent metastatic prostate cancerUrology, 2001
- Intermittent Androgen Suppression in the Treatment of Metastatic Prostate CancerEuropean Urology, 2000
- Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunctionInternational Journal Of Impotence Research, 1999
- Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: A pilot studyUrology, 1996
- Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour modelThe Journal of Steroid Biochemistry and Molecular Biology, 1996
- Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III eortc trial (30853)Urology, 1993
- The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.Journal of Clinical Oncology, 1993
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989